(Q51997119)

19 April 2018

title

Rifampin reduces plasma concentrations and effects of zolpidem. (English)

1 reference

19 April 2018

1 reference

Villikka K

1

1 reference

19 April 2018

Kivistö KT

series ordinal

2

1 reference

19 April 2018

Luurila H

series ordinal

3

1 reference

19 April 2018

Neuvonen PJ

series ordinal

4

1 reference

19 April 2018

language of work or name

English

0 references

publication date

1 December 1997

1 reference

19 April 2018

Clinical Pharmacology & Therapeutics

published in

1 reference

19 April 2018

volume

62

1 reference

19 April 2018

issue

6

1 reference

19 April 2018

page(s)

629-634

1 reference

19 April 2018

Saccadic eye movement analysis as a measure of drug effects on human psychomotor performance

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990082-5

Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990082-5

Zolpidem. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990082-5

Pharmacokinetic drug interactions with rifampicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990082-5

Rifampin drastically reduces plasma concentrations and effects of oral midazolam.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990082-5

Triazolam is ineffective in patients taking rifampin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990082-5

Concentrations and effects of zopiclone are greatly reduced by rifampicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990082-5

Simultaneous determination of zolpidem and zopiclone in human plasma by gas chromatography-nitrogen-phosphorus detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990082-5

Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990082-5

The effect of antipyrine and rifampin on the metabolism of diazepam.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990082-5

Clinically significant pharmacokinetic drug interactions with carbamazepine. An update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990082-5

Concentrations and effects of oral midazolam are greatly reduced in patients treated with carbamazepine or phenytoin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990082-5

10.1016/S0009-9236(97)90082-5

7 January 2021

Identifiers

DOI

1 reference

19 April 2018

1 reference

19 April 2018